Pharmadrug IncCanadian Securities Exchange:PHRXView on OTC Pink - Current Information
- LAST PRICE0.0200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PHRX |
|---|---|---|
| 02:48 ET | 38000 | 0.015 |
| 03:35 ET | 2000 | 0.02 |
Nov 15, 2024
PharmaDrug Announces Issuance of Debenture Units, from 5:31PM ET on Friday Nov 15, 2024 by Dow Jones
5:31PM ET on Friday Nov 15, 2024 by Dow Jones
Oct 31, 2024
PharmaDrug Announces Proposed Issuance of Debenture Units, from 5:56PM ET on Thursday Oct 31, 2024 by Dow Jones
5:56PM ET on Thursday Oct 31, 2024 by Dow JonesPharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases, from 8:59AM ET on Thursday Oct 31, 2024 by Dow Jones
8:59AM ET on Thursday Oct 31, 2024 by Dow Jones
Industry Peers
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pharmadrug Inc | 2.1M | -0.1x | --- |
Magna Terra Minerals Inc | 2.1M | -3.0x | --- |
Southern Empire Resources Corp | 2.0M | -0.7x | --- |
Goldhills Holding Ltd | 2.0M | -4.1x | --- |
Panther Minerals Inc | 2.0M | -0.2x | --- |
Terra Clean Energy Corp | 2.2M | -0.6x | --- |
Company Information
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.
Contact Information
- Headquarters
- 77 King St. West, Suite 2905TORONTO, ON, Canada M5K 1H1
- Phone
- 647-202-1824
- Fax
- 416-765-0029
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | --- |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | --- |
Pharmadrug Inc does not pay a dividend. | |
Beta | --- |
EPS | --- |
Book Value | --- |
P/E Ratio | -0.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
